Mariner’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $581K | Buy |
+11,946
| New | +$581K | ﹤0.01% | 2210 |
|
|
2025
Q1 | – | Sell |
-5,765
| Closed | -$227K | – | 3470 |
|
|
2024
Q4 | $227K | Sell |
5,765
-746
| -11% | -$29.4K | ﹤0.01% | 2893 |
|
|
2024
Q3 | $306K | Sell |
6,511
-274
| -4% | -$12.9K | ﹤0.01% | 2553 |
|
|
2024
Q2 | $367K | Sell |
6,785
-1,413
| -17% | -$76.4K | ﹤0.01% | 2297 |
|
|
2024
Q1 | $559K | Buy |
8,198
+2,162
| +36% | +$147K | ﹤0.01% | 1943 |
|
|
2023
Q4 | $378K | Sell |
6,036
-1,454
| -19% | -$91K | ﹤0.01% | 2151 |
|
|
2023
Q3 | $340K | Buy |
7,490
+938
| +14% | +$42.6K | ﹤0.01% | 2048 |
|
|
2023
Q2 | $368K | Buy |
+6,552
| New | +$368K | ﹤0.01% | 1965 |
|
|
2022
Q4 | – | Sell |
-3,586
| Closed | -$234K | – | 2759 |
|
|
2022
Q3 | $234K | Buy |
+3,586
| New | +$234K | ﹤0.01% | 1948 |
|